Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Human Amniotic Mesenchymal Stem Cells

Home DrugsHuman Amniotic Mesenchymal Stem Cells

Human Amniotic Mesenchymal Stem Cells

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

METHODS AND COMPOSITIONS FOR TREATING DRY EYE, TEAR HYPEROSMOLARITY-INDUCED PATHOLOGICAL CHANGES, AND OTHER OCULAR CONDITIONS
US 20250144153 A1Applicant: MAM HOLDINGS OF WEST FLORIDA L L CPriority: 2023
US
WO
2 publications
Equine amniotic membrane-derived mesenchymal stem cells
US 9650604 B2Applicant: KANG STEM BIOTECH CO LTDPriority: 2011
US
2 publications
METHODS AND COMPOSITIONS FOR TREATING OCULAR GRAFT VERSUS HOST DISEASE AND OTHER OCULAR CONDITIONS
US 2024216437 A1Applicant: MAM HOLDINGS OF WEST FLORIDA L L CPriority: 2023
US
2 publications
Human Bone Stem Cells From Amniotic Mesenchymal Cell Layer
US 2010254954 A1Applicant: SAKURAGAWA NORIOPriority: 2010
US
Use of human amniotic mesenchymal stem cell exosome
CN 104382827 AApplicant: GUANGZHOU SALIAI STEMCELL SCIENCE & TECHNOLOGY CO LTDPriority: 2014
CN
Amniotic membrane mesenchymal stem cell release molecule (ASRM) as well as preparation method and application of ASRM
CN 107744526 AApplicant: UNIV NANJING MEDICALPriority: 2017
CN
STEM CELL FORMULATION FOR ANTI-AGING REPAIR AND PREPARATION METHOD THEREFOR
CN 110475563 AApplicant: YANG ZHIPriority: 2018
CN
Use of hAMSCs (Human Amniotic Mesenchymal Stem Cells) in preparing drug for treating acute graft-versus-host disease
CN 109674818 AApplicant: NANFANG HOSPITAL SOUTHERN MEDICAL UNIVPriority: 2018
CN
Compositions derived from human amniotic cells and related methods
CN 114340647 AApplicant: EEXOLOT BARKE CO LTDPriority: 2019
CN
Preparation of mesenchymal stem cell and application of mesenchymal stem cell in preparation of drugs for treating aches
CN 110731969 AApplicant: BEIJING ZHONGGUANG TIANYI BIOLOGICAL TECH CO LTDPriority: 2019
CN

Page 1 of 3